 | • レポートコード：MRC2-11QY02608 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗自殺薬のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬・抗不安薬、抗精神病薬、NMDA拮抗薬、抗生物質アナログ、その他）市場規模、用途別（病院、クリニック、家庭用）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗自殺薬の競争状況、市場シェア ・世界の抗自殺薬市場：種類別市場規模 2015年-2020年（抗うつ薬・抗不安薬、抗精神病薬、NMDA拮抗薬、抗生物質アナログ、その他） ・世界の抗自殺薬市場：種類別市場規模予測 2021年-2026年（抗うつ薬・抗不安薬、抗精神病薬、NMDA拮抗薬、抗生物質アナログ、その他） ・世界の抗自殺薬市場：用途別市場規模 2015年-2020年（病院、クリニック、家庭用） ・世界の抗自殺薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、家庭用） ・北米の抗自殺薬市場分析：米国、カナダ ・ヨーロッパの抗自殺薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗自殺薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗自殺薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗自殺薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer, Inc.、AstraZeneca plc、Eli Lilly and Company、Allergan plc、GlaxoSmithkline plc、Merck & Co., Inc.、H. Lundbeck A/S、NeuroRx, Inc.、Johnson & Johnson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Anti-Suicide Drug Market
The global Anti-Suicide Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anti-Suicide Drug Scope and Market Size
Anti-Suicide Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Suicide Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Suicide Drug market is segmented into
Anti-Depressants and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Others
Segment by Application, the Anti-Suicide Drug market is segmented into
Hospital
Clinic
Home Use
Regional and Country-level Analysis
The Anti-Suicide Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Suicide Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Suicide Drug Market Share Analysis
Anti-Suicide Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Suicide Drug business, the date to enter into the Anti-Suicide Drug market, Anti-Suicide Drug product introduction, recent developments, etc.
The major vendors covered:
Pfizer, Inc.
AstraZeneca plc
Eli Lilly and Company
Allergan plc
GlaxoSmithkline plc
Merck & Co., Inc.
H. Lundbeck A/S
NeuroRx, Inc.
Johnson & Johnson
1 Study Coverage
1.1 Anti-Suicide Drug Product Introduction
1.2 Market Segments
1.3 Key Anti-Suicide Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Suicide Drug Market Size Growth Rate by Type
1.4.2 Anti-Depressants and Anti-Anxiety Drugs
1.4.3 Anti-Psychotic Drugs
1.4.4 NMDA Antagonist
1.4.5 Antibiotic Analog
1.4.6 Others
1.5 Market by Application
1.5.1 Global Anti-Suicide Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Use
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Suicide Drug Market Size, Estimates and Forecasts
2.1.1 Global Anti-Suicide Drug Revenue 2015-2026
2.1.2 Global Anti-Suicide Drug Sales 2015-2026
2.2 Global Anti-Suicide Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Suicide Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Suicide Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Suicide Drug Competitor Landscape by Players
3.1 Anti-Suicide Drug Sales by Manufacturers
3.1.1 Anti-Suicide Drug Sales by Manufacturers (2015-2020)
3.1.2 Anti-Suicide Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Suicide Drug Revenue by Manufacturers
3.2.1 Anti-Suicide Drug Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Suicide Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Suicide Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Suicide Drug Revenue in 2019
3.2.5 Global Anti-Suicide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Suicide Drug Price by Manufacturers
3.4 Anti-Suicide Drug Manufacturing Base Distribution, Product Types
3.4.1 Anti-Suicide Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Suicide Drug Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Suicide Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Suicide Drug Market Size by Type (2015-2020)
4.1.1 Global Anti-Suicide Drug Sales by Type (2015-2020)
4.1.2 Global Anti-Suicide Drug Revenue by Type (2015-2020)
4.1.3 Anti-Suicide Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Suicide Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Suicide Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Suicide Drug Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Suicide Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Suicide Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Suicide Drug Market Size by Application (2015-2020)
5.1.1 Global Anti-Suicide Drug Sales by Application (2015-2020)
5.1.2 Global Anti-Suicide Drug Revenue by Application (2015-2020)
5.1.3 Anti-Suicide Drug Price by Application (2015-2020)
5.2 Anti-Suicide Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Suicide Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Suicide Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Suicide Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-Suicide Drug by Country
6.1.1 North America Anti-Suicide Drug Sales by Country
6.1.2 North America Anti-Suicide Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Suicide Drug Market Facts & Figures by Type
6.3 North America Anti-Suicide Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-Suicide Drug by Country
7.1.1 Europe Anti-Suicide Drug Sales by Country
7.1.2 Europe Anti-Suicide Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Suicide Drug Market Facts & Figures by Type
7.3 Europe Anti-Suicide Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-Suicide Drug by Region
8.1.1 Asia Pacific Anti-Suicide Drug Sales by Region
8.1.2 Asia Pacific Anti-Suicide Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Suicide Drug Market Facts & Figures by Type
8.3 Asia Pacific Anti-Suicide Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-Suicide Drug by Country
9.1.1 Latin America Anti-Suicide Drug Sales by Country
9.1.2 Latin America Anti-Suicide Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Suicide Drug Market Facts & Figures by Type
9.3 Central & South America Anti-Suicide Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-Suicide Drug by Country
10.1.1 Middle East and Africa Anti-Suicide Drug Sales by Country
10.1.2 Middle East and Africa Anti-Suicide Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Suicide Drug Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Suicide Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Corporation Information
11.1.2 Pfizer, Inc. Description and Business Overview
11.1.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer, Inc. Anti-Suicide Drug Products Offered
11.1.5 Pfizer, Inc. Related Developments
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Corporation Information
11.2.2 AstraZeneca plc Description and Business Overview
11.2.3 AstraZeneca plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca plc Anti-Suicide Drug Products Offered
11.2.5 AstraZeneca plc Related Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Corporation Information
11.3.2 Eli Lilly and Company Description and Business Overview
11.3.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly and Company Anti-Suicide Drug Products Offered
11.3.5 Eli Lilly and Company Related Developments
11.4 Allergan plc
11.4.1 Allergan plc Corporation Information
11.4.2 Allergan plc Description and Business Overview
11.4.3 Allergan plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Allergan plc Anti-Suicide Drug Products Offered
11.4.5 Allergan plc Related Developments
11.5 GlaxoSmithkline plc
11.5.1 GlaxoSmithkline plc Corporation Information
11.5.2 GlaxoSmithkline plc Description and Business Overview
11.5.3 GlaxoSmithkline plc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithkline plc Anti-Suicide Drug Products Offered
11.5.5 GlaxoSmithkline plc Related Developments
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Corporation Information
11.6.2 Merck & Co., Inc. Description and Business Overview
11.6.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck & Co., Inc. Anti-Suicide Drug Products Offered
11.6.5 Merck & Co., Inc. Related Developments
11.7 H. Lundbeck A/S
11.7.1 H. Lundbeck A/S Corporation Information
11.7.2 H. Lundbeck A/S Description and Business Overview
11.7.3 H. Lundbeck A/S Sales, Revenue and Gross Margin (2015-2020)
11.7.4 H. Lundbeck A/S Anti-Suicide Drug Products Offered
11.7.5 H. Lundbeck A/S Related Developments
11.8 NeuroRx, Inc.
11.8.1 NeuroRx, Inc. Corporation Information
11.8.2 NeuroRx, Inc. Description and Business Overview
11.8.3 NeuroRx, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 NeuroRx, Inc. Anti-Suicide Drug Products Offered
11.8.5 NeuroRx, Inc. Related Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Corporation Information
11.9.2 Johnson & Johnson Description and Business Overview
11.9.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Johnson & Johnson Anti-Suicide Drug Products Offered
11.9.5 Johnson & Johnson Related Developments
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Corporation Information
11.1.2 Pfizer, Inc. Description and Business Overview
11.1.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer, Inc. Anti-Suicide Drug Products Offered
11.1.5 Pfizer, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-Suicide Drug Market Estimates and Projections by Region
12.1.1 Global Anti-Suicide Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Suicide Drug Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Suicide Drug Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Suicide Drug Sales Forecast (2021-2026)
12.2.2 North America: Anti-Suicide Drug Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Suicide Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Suicide Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Suicide Drug Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Suicide Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Suicide Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Suicide Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Suicide Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Suicide Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Suicide Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Suicide Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Suicide Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Suicide Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Suicide Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Suicide Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Suicide Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Suicide Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Suicide Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-Suicide Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Suicide Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anti-Suicide Drug Market Segments
Table 2. Ranking of Global Top Anti-Suicide Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Suicide Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Anti-Depressants and Anti-Anxiety Drugs
Table 5. Major Manufacturers of Anti-Psychotic Drugs
Table 6. Major Manufacturers of NMDA Antagonist
Table 7. Major Manufacturers of Antibiotic Analog
Table 8. Major Manufacturers of Others
Table 9. Global Anti-Suicide Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Anti-Suicide Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Anti-Suicide Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Anti-Suicide Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Anti-Suicide Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Anti-Suicide Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Anti-Suicide Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Anti-Suicide Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Anti-Suicide Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Suicide Drug as of 2019)
Table 18. Anti-Suicide Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Anti-Suicide Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Anti-Suicide Drug Price (2015-2020) (USD/Pcs)
Table 21. Anti-Suicide Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Anti-Suicide Drug Product Type
Table 23. Date of International Manufacturers Enter into Anti-Suicide Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-Suicide Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Anti-Suicide Drug Sales Share by Type (2015-2020)
Table 27. Global Anti-Suicide Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Anti-Suicide Drug Revenue Share by Type (2015-2020)
Table 29. Anti-Suicide Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Anti-Suicide Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Anti-Suicide Drug Sales Share by Application (2015-2020)
Table 32. North America Anti-Suicide Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Anti-Suicide Drug Sales Market Share by Country (2015-2020)
Table 34. North America Anti-Suicide Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Anti-Suicide Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Anti-Suicide Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Anti-Suicide Drug Sales Market Share by Type (2015-2020)
Table 38. North America Anti-Suicide Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Anti-Suicide Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Anti-Suicide Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Anti-Suicide Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Anti-Suicide Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Anti-Suicide Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Anti-Suicide Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Anti-Suicide Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Anti-Suicide Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Anti-Suicide Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Anti-Suicide Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Anti-Suicide Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Anti-Suicide Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Anti-Suicide Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Anti-Suicide Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Anti-Suicide Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Anti-Suicide Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Anti-Suicide Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Anti-Suicide Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Anti-Suicide Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Anti-Suicide Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Anti-Suicide Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Anti-Suicide Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Anti-Suicide Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Anti-Suicide Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Anti-Suicide Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Anti-Suicide Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Anti-Suicide Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anti-Suicide Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Anti-Suicide Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Anti-Suicide Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Anti-Suicide Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Anti-Suicide Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Anti-Suicide Drug Sales Market Share by Application (2015-2020)
Table 72. Pfizer, Inc. Corporation Information
Table 73. Pfizer, Inc. Description and Major Businesses
Table 74. Pfizer, Inc. Anti-Suicide Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Pfizer, Inc. Product
Table 76. Pfizer, Inc. Recent Development
Table 77. AstraZeneca plc Corporation Information
Table 78. AstraZeneca plc Description and Major Businesses
Table 79. AstraZeneca plc Anti-Suicide Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AstraZeneca plc Product
Table 81. AstraZeneca plc Recent Development
Table 82. Eli Lilly and Company Corporation Information
Table 83. Eli Lilly and Company Description and Major Businesses
Table 84. Eli Lilly and Company Anti-Suicide Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Eli Lilly and Company Product
Table 86. Eli Lilly and Company Recent Development
Table 87. Allergan plc Corporation Information
Table 88. Allergan plc Description and Major Businesses
Table 89. Allergan plc Anti-Suicide Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Allergan plc Product
Table 91. Allergan plc Recent Development
Table 92. GlaxoSmithkline plc Corporation Information
Table 93. GlaxoSmithkline plc Description and Major Businesses
Table 94. GlaxoSmithkline plc Anti-Suicide Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. GlaxoSmithkline plc Product
Table 96. GlaxoSmithkline plc Recent Development
Table 97. Merck & Co., Inc. Corporation Information
Table 98. Merck & Co., Inc. Description and Major Businesses
Table 99. Merck & Co., Inc. Anti-Suicide Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Merck & Co., Inc. Product
Table 101. Merck & Co., Inc. Recent Development
Table 102. H. Lundbeck A/S Corporation Information
Table 103. H. Lundbeck A/S Description and Major Businesses
Table 104. H. Lundbeck A/S Anti-Suicide Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. H. Lundbeck A/S Product
Table 106. H. Lundbeck A/S Recent Development
Table 107. NeuroRx, Inc. Corporation Information
Table 108. NeuroRx, Inc. Description and Major Businesses
Table 109. NeuroRx, Inc. Anti-Suicide Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. NeuroRx, Inc. Product
Table 111. NeuroRx, Inc. Recent Development
Table 112. Johnson & Johnson Corporation Information
Table 113. Johnson & Johnson Description and Major Businesses
Table 114. Johnson & Johnson Anti-Suicide Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Johnson & Johnson Product
Table 116. Johnson & Johnson Recent Development
Table 117. Global Anti-Suicide Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 118. Global Anti-Suicide Drug Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Anti-Suicide Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Anti-Suicide Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Anti-Suicide Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. North America: Anti-Suicide Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Anti-Suicide Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. Europe: Anti-Suicide Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Anti-Suicide Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 126. Asia Pacific: Anti-Suicide Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Anti-Suicide Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Latin America: Anti-Suicide Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Anti-Suicide Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Middle East and Africa: Anti-Suicide Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Anti-Suicide Drug Players
Table 135. Anti-Suicide Drug Customers List
Table 136. Anti-Suicide Drug Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Suicide Drug Product Picture
Figure 2. Global Anti-Suicide Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Anti-Depressants and Anti-Anxiety Drugs Product Picture
Figure 4. Anti-Psychotic Drugs Product Picture
Figure 5. NMDA Antagonist Product Picture
Figure 6. Antibiotic Analog Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anti-Suicide Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Home Use
Figure 12. Anti-Suicide Drug Report Years Considered
Figure 13. Global Anti-Suicide Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Anti-Suicide Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Anti-Suicide Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Anti-Suicide Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Anti-Suicide Drug Sales Market Share by Region in 2019
Figure 18. Global Anti-Suicide Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Anti-Suicide Drug Revenue Market Share by Region in 2019
Figure 20. Global Anti-Suicide Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Anti-Suicide Drug Revenue in 2019
Figure 22. Anti-Suicide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Anti-Suicide Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Anti-Suicide Drug Sales Market Share by Type in 2019
Figure 25. Global Anti-Suicide Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Anti-Suicide Drug Revenue Market Share by Type in 2019
Figure 27. Global Anti-Suicide Drug Market Share by Price Range (2015-2020)
Figure 28. Global Anti-Suicide Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Anti-Suicide Drug Sales Market Share by Application in 2019
Figure 30. Global Anti-Suicide Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Anti-Suicide Drug Revenue Market Share by Application in 2019
Figure 32. North America Anti-Suicide Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Anti-Suicide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Anti-Suicide Drug Sales Market Share by Country in 2019
Figure 35. North America Anti-Suicide Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Anti-Suicide Drug Market Share by Type in 2019
Figure 41. North America Anti-Suicide Drug Market Share by Application in 2019
Figure 42. Europe Anti-Suicide Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Anti-Suicide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Anti-Suicide Drug Sales Market Share by Country in 2019
Figure 45. Europe Anti-Suicide Drug Revenue Market Share by Country in 2019
Figure 46. Germany Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Anti-Suicide Drug Market Share by Type in 2019
Figure 57. Europe Anti-Suicide Drug Market Share by Application in 2019
Figure 58. Asia Pacific Anti-Suicide Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Anti-Suicide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Anti-Suicide Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Anti-Suicide Drug Revenue Market Share by Region in 2019
Figure 62. China Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Anti-Suicide Drug Market Share by Type in 2019
Figure 85. Asia Pacific Anti-Suicide Drug Market Share by Application in 2019
Figure 86. Latin America Anti-Suicide Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Anti-Suicide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Anti-Suicide Drug Sales Market Share by Country in 2019
Figure 89. Latin America Anti-Suicide Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Anti-Suicide Drug Market Share by Type in 2019
Figure 97. Latin America Anti-Suicide Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Anti-Suicide Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Anti-Suicide Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Anti-Suicide Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Anti-Suicide Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Anti-Suicide Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Anti-Suicide Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Anti-Suicide Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Anti-Suicide Drug Market Share by Application in 2019
Figure 110. North America Anti-Suicide Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Anti-Suicide Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Anti-Suicide Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Anti-Suicide Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Anti-Suicide Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Anti-Suicide Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Anti-Suicide Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Anti-Suicide Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Anti-Suicide Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Anti-Suicide Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
抗がん剤の世界市場（～2026年） Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones. China and India are expected to of…- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 止瀉薬の世界市場（～2026年） Market Analysis and Insights: Global Anti Diarrheal Drugs Market The global Anti Diarrheal Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti Diarrheal Drugs Scope and Market Size Anti Diarrheal Drugs market is…